Data / Form D filings / Oncotelic Therapeutics, Inc.
Oncotelic Therapeutics, Inc.: Form D filings
Oncotelic Therapeutics, Inc., a biotechnology company in Agoura Hills, CA, filed 8 Form D notices with the SEC between 2010 and 2026. The latest, on July 22, 2026, reports $711,840 sold of a $711,840 offering to 33 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 29397 AGOURA ROAD SUITE 107, Agoura Hills, CA, 91301
- Phone
- (650) 635-7000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 908259
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | New notice | $711,840 | $711,840 | 33 | Jul 10, 2026 | sec.gov | |
| Dec 11, 2025 | New notice | $12,500,000 | $275,000 | $12,225,000 | 4 | Dec 4, 2025 | sec.gov |
| Jul 13, 2023 | New notice | $5,000,000 | $0 | $5,000,000 | 15 | Yet to occur | sec.gov |
| Aug 4, 2020 | New notice | $5,000,000 | $2,000,000 | $3,000,000 | 24 | Jul 23, 2020 | sec.gov |
| May 7, 2019 | New notice | $1,200,000 | $600,000 | $600,000 | 4 | Apr 22, 2019 | sec.gov |
| May 7, 2019 | New notice | $27,000,000 | $27,000,000 | 26 | Apr 22, 2019 | sec.gov | |
| Apr 25, 2018 | New notice | $12,000,000 | $2,925,000 | $9,075,000 | 38 | Apr 12, 2018 | sec.gov |
| Mar 26, 2010 | New notice | $7,500,000 | $7,500,000 | 5 | Mar 12, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| VUONG TRIEU | Executive Officer, Director | |
| STEVEN KING | Director | |
| ANTHONY MAIDA | Executive Officer, Director | |
| SHAH AMIT | Executive Officer | |
| SEYMOUR FEIN | Executive Officer | |
| SARAN SAUND | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jul 20, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Oncotelic Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.